Kaposi sarcoma herpesvirus -associated multicentric castleman disease
Clinical trials for Kaposi sarcoma herpesvirus -associated multicentric castleman disease explained in plain language.
Never miss a new study
Get alerted when new Kaposi sarcoma herpesvirus -associated multicentric castleman disease trials appear
Sign up with your email to follow new studies for Kaposi sarcoma herpesvirus -associated multicentric castleman disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial targets deadly inflammation in HIV patients
Disease control Recruiting nowThis study tests a drug called pacritinib in people with HIV who have two rare conditions caused by the Kaposi sarcoma herpesvirus (KSHV): KSHV-associated multicentric Castleman disease (MCD) and KSHV inflammatory cytokine syndrome (KICS). These conditions cause severe, life-thre…
Matched conditions: KAPOSI SARCOMA HERPESVIRUS -ASSOCIATED MULTICENTRIC CASTLEMAN DISEASE
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a tiny device speed up cancer diagnosis for people with HIV?
Diagnosis Recruiting nowThis study tests new diagnostic approaches for lymphoma and multicentric Castleman disease in people living with HIV who have swollen lymph nodes. Researchers will compare standard biopsies with fine needle aspiration and a new nucleic acid amplification device called TINY. The g…
Matched conditions: KAPOSI SARCOMA HERPESVIRUS -ASSOCIATED MULTICENTRIC CASTLEMAN DISEASE
Sponsor: Indiana University • Aim: Diagnosis
Last updated Aug 30, 2026 00:00 UTC